Hepatitis A and B vaccination in elderly travellers

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG44__%2F11%3A00002606" target="_blank" >RIV/60162694:G44__/11:00002606 - isvavai.cz</a>

Výsledek na webu

<a href="http://www.touchgastroenterology.com/articles/hepatitis-and-b-vaccination-elderly-travellers-0?page=0,8" target="_blank" >http://www.touchgastroenterology.com/articles/hepatitis-and-b-vaccination-elderly-travellers-0?page=0,8</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Hepatitis A and B vaccination in elderly travellers

Popis výsledku v původním jazyce

Hepatitis A and hepatitis B viruses (HAV and HBV, respectively) are associated with significant morbidity, linked with acute illness, a substantial healthcare burden and potential mortality. An increasing number of people, with increasing median age, travel from areas of low endemicity to countries that have intermediate or high endemicity for HAV and HBV and are conse uently susceptible to infection. Pre-travel vaccination is, therefore, warranted, but the responce to HAV and HBV vaccination in elderlyinindividuals could be compromised by senescence of the immune system, thus potentially increasing the vulnerability of the elderly to these infections. Studies with monovalent hepatitis A and B vaccines or combination hepatitis A and B vaccine show good efficacy in adults in general but ohly a limited number of studies have assessed the immune response in older adults. This article presents an overview of the risk factors for acqusition of HAV and HBV in the elderly traveller and evalu

Název v anglickém jazyce

Hepatitis A and B vaccination in elderly travellers

Popis výsledku anglicky

Hepatitis A and hepatitis B viruses (HAV and HBV, respectively) are associated with significant morbidity, linked with acute illness, a substantial healthcare burden and potential mortality. An increasing number of people, with increasing median age, travel from areas of low endemicity to countries that have intermediate or high endemicity for HAV and HBV and are conse uently susceptible to infection. Pre-travel vaccination is, therefore, warranted, but the responce to HAV and HBV vaccination in elderlyinindividuals could be compromised by senescence of the immune system, thus potentially increasing the vulnerability of the elderly to these infections. Studies with monovalent hepatitis A and B vaccines or combination hepatitis A and B vaccine show good efficacy in adults in general but ohly a limited number of studies have assessed the immune response in older adults. This article presents an overview of the risk factors for acqusition of HAV and HBV in the elderly traveller and evalu

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FN - Epidemiologie, infekční nemoci a klinická imunologie

OECD FORD obor

—

Projekt

—

Návaznosti

Z - Vyzkumny zamer (s odkazem do CEZ)

Rok uplatnění

2011

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

European Gastroenterology & Hepatology Review

ISSN

1758-3799

e-ISSN

—

Svazek periodika

7

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

9

Strana od-do

84-92

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—